Major trial tests vaccine to block Cancer-Linked oral HPV in HIV-Positive men
NCT ID NCT04255849
Summary
This study is testing whether the 9-valent HPV vaccine can prevent persistent oral HPV infections in men living with HIV. It involves 700 adult men in Puerto Rico, Mexico, and Brazil who will receive either the real vaccine or a placebo. The goal is to see if vaccination can stop the virus from taking hold in the mouth, which could lower the risk of developing HPV-related throat cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV-1 INFECTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Instituto Nacional de Salud Pública, Mexico
Cuernavaca, Morelos, 62209, Mexico
-
Universidade de São Paulo
São Paulo, São Paulo, 05403-911, Brazil
-
University of Puerto Rico AIDS Clinical Trials Unit
San Juan, Purto Rico, 00935, Puerto Rico
Conditions
Explore the condition pages connected to this study.